Tax concessions available for research
07 March, 2007 by Wendy Cramer, JournalistThe R&D Tax Concession is designed to fuel local research and development and is available to all sectors of industry
Nominations open for 2007 Victoria Prize and Fellowships
23 February, 2007The Minister for Innovation, John Brumby has urged leading and emerging scientists, engineers and innovators to nominate for the Victoria Prize and Victoria Fellowships science awards.
Brisbane biotech signs Australian first agreement
21 February, 2007Brisbane biotech company BioChip Innovations has become the first Australian company to sign a research collaboration agreement with Singapore’s Institute of Microelectronics (IME).
Queensland company wows New York
16 February, 2007Minister for State Development John Mickel has congratulated Brisbane-based company BSD Robotics for its success at the Australian Innovation Shootout in New York as part of G’Day USA Australia Week.
ATSE seeks new CEO
22 January, 2007The Australian Academy of Technological Sciences and Engineering (ATSE) is advertising nationally for a chief executive officer to implement ATSE’s strategy, which includes national and international interactions dealing with technological issues of importance to the broad Australian community.
Leading cancer researcher is new bioscience boss
15 January, 2007Professor Brandon Wainwright, cancer and cystic fibrosis researcher, is the new director of an Australian bioscience flagship, the Institute for Molecular Bioscience (IMB) at the University of Queensland (UQ).
Australian companies offered fast track opportunity
15 December, 2006The Company Chemists Association has offered Australian companies the opportunity to attend New Frontiers 2007, business seminar and business speed dating event, which seeks to help international companies that are keen to expand into the United Kingdom pharmacy market to fast track their business and understanding of the market.
Qld company raises millions for drug research
29 September, 2006A Queensland biotechnology company has raised AU$11.9 m to fund the development of new types of therapeutic drugs.
Protecting intellectual property through the innovation patent system
11 September, 2006Scientists and researchers often have great ideas. Some ideas are profound, long-term revelations which lead to new scientific theories, methodologies or technologies, while others are more ephemeral
Embrex and Shenzhen Neptunus announce joint project
21 August, 2006Embrex has delivered an Egg Remover system and an Inovoject system to Shenzhen Neptunus Interlong Bio-technique (SNI). These have been installed in SNI's human influenza vaccine manufacturing facility at High-Tech Industrial Park Guangming, Shenzhen.
New institute tackles unsolved medical questions
10 July, 2006The University of Sydney has officially launched a new medical research facility – the Bosch Institute.
A new approach to open-access publishing
09 June, 2006PLoS ONE is the latest innovation from the Public Library of Science, a non-profit organisation making the world’s research literature a freely available public resource.
New centre opens to study a small matter
07 June, 2006Australia will be positioned to take a world-leading role in the area, with the establishment of the Australian Research Council Centre of Excellence for AntiMatter-Matter Studies (CAMS), which was launched today by ARC chief executive professor Peter Høj.
Extensive resource built for gene silencing
24 March, 2006Human gene silencing may become a little easier for scientists worldwide with an international public-private research team led by scientists at the Broad Institute of MIT and Harvard announcing the construction and availability of an extensive library of molecular reagents.
Qiagen and Eppendorf form alliance
03 February, 2006Qiagen and Eppendorf have announced that they have formed a strategic alliance that includes co-development and co-marketing of complementary and optimised products. The alliance is intended to link the brands and product lines and to ensure the highest compatibility of their products targeting the research, applied testing and molecular diagnostics.
